Blog | Veristat Insightful Perspectives

Contact Veristat Now


Request A Proposal

Contact Us

Understanding When to Submit an IND Application to the FDA

November 20, 2019

An Interview with Kevin Hennegan, Senior Regulatory Strategist, Veristat

Read More

Selecting the Right EDC System for a Clinical Program

November 14, 2019

Understanding the Various Considerations for EDC Selection

An Interview with  Kathleen Boruchowski, Director of Data Management, Veristat 

Read More

Regulatory Guidance Monthly Review - October 2019

November 6, 2019

October 2019 Updates from FDA 


Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA)  that are pertinent to the governance of clinical trials and drug, biologic, or medical device development and approval.   Below are the relevant links to updates provided in October 2019.

 

Read More